klow formula GHK-CU/BPC-157/TB-500/KPV KLOW Blend - Simple

A biological approach to treating disc degeneration: not for today, but maybe for tomorrow

This is why we focus so heavily on delivery systems

J Neurosurg 113 : 12241229

Lastly, IN-administered peptides have the potential to directly enter the systemic circulation, avoiding first pass metabolism in the liver, so in certain limited cases peripheral plasma peptide pharmacokinetics have been studied and are well-reviewed here [16,17,22], providing additional insight into the potential for off-target effects [16] and also emphasizing the importance of the local intranasal mechanisms of peptide degradation [23]

[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Rosenberg H.R., Culik R

M.BroughD.LemarchandE